FDA Adverse Event Injury Summary report: N

ENDEAVOR SPRINT RX CORONARY STENT SYSTEM

MDR report key: 2000394 · Received February 18, 2011

Report

Report Number
2953200-2011-00437
Event Type
Injury
Date Received
February 18, 2011
Date of Event
December 23, 2010
Report Date
January 21, 2011
Manufacturer
MEDTRONIC CARDIOVASCULAR GALWAY
Product Code
NIQ
PMA / PMN Number
P060033
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4). EVAL, RESULTS: (MI, STENT THROMBOSIS AND CVA).

Description of Event or Problem · 1

AN ENDEAVOR SPRINT RAPID EXCHANGE (RX) DRUG ELUTING STENT WAS IMPLANTED IN THE MID LAD AND DUE TO PLAQUE SHIFT SECOND ENDEAVOR SPRINT (RX) DRUG ELUTING STENT WAS IMPLANTED TO THE DISTAL EDGE OF THE INITIAL STENT. APPROXIMATELY 2 DAYS POST INDEX PROCEDURE, THE PT HAD A MYOCARDIAL INFARCTION WITH ISCHEMIC CARDIOMYOPATHY AND THROMBUS. THE PT ALSO DEVELOPED A CHANGE IN MENTAL STATUS AND FEVER. THE PT WAS DIAGNOSED WITH AN EMBOLIC CVA AND ONSET OF RIGHT EYE DEFICIT SECONDARY TO EMBOLIC EVENTS FOR MITRAL VALVE ENDOCARDITIS, NO INTRACEREBRAL BLEED. IT IS REPORTED THAT THE PT WAS TREATED WITH MEDICATION AND IS CONTINUING WITH TREATMENT. INVESTIGATOR HAS INDICATED THAT THE EVENT WAS POSSIBLY RELATED TO THE STUDY DEVICE AND THE STUDY PROCEDURE. (REF MFR# 2953200-2011-00436).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDEAVOR SPRINT RX CORONARY STENT SYSTEM NIQ MEDTRONIC CARDIOVASCULAR GALWAY NA UNK

Patients

Seq Age Sex Outcome Treatment
1 67 YR Required Intervention